Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2008-11-19FDA Approved: CHLORPROMAZINE HYDROCHLORIDE — Supplemental Application (Upsher-Smith Laboratories, LLC)
The FDA approved a supplemental application for chlorpromazine hydrochloride (Upsher-Smith Laboratories, LLC).
-
FDA approval · 2008-11-19FDA Approved: CHLORPROMAZINE HYDROCHLORIDE — Supplemental Application (Upsher-Smith Laboratories, LLC)
FDA approved a supplemental application for chlorpromazine hydrochloride from Upsher-Smith Laboratories, approving changes to the approved d…
-
FDA approval · 2008-11-19FDA Approved: HALOPERIDOL DECANOATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Haloperidol decanoate by Hikma Pharmaceuticals USA Inc., indicating the supplement has been appr…
-
FDA approval · 2008-11-19FDA Approved: CHLORPROMAZINE HYDROCHLORIDE — Supplemental Application (Upsher-Smith Laboratories, LLC)
The FDA approved a supplemental application for chlorpromazine hydrochloride from Upsher-Smith Laboratories, LLC. This action updates the ap…
-
FDA approval · 2008-11-19FDA Approved: CLOZAPINE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for Clozapine by Mylan Pharmaceuticals Inc., granting approval for a generic Clozapine product.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2008-11-18FDA Approved: FLUPHENAZINE HYDROCHLORIDE — Supplemental Application (Fresenius Kabi USA, LLC)
FDA approved a supplemental application for fluphenazine hydrochloride (generic) from Fresenius Kabi USA, LLC.
-
FDA approval · 2008-10-30FDA Approved: HALOPERIDOL DECANOATE — Supplemental Application (Fresenius Kabi USA, LLC)
The FDA approved a supplemental application for HALOPERIDOL DECANOATE from Fresenius Kabi USA, LLC.
-
FDA approval · 2008-10-30FDA Approved: HALOPERIDOL — Supplemental Application (Fresenius Kabi USA, LLC)
FDA approved a supplemental application for haloperidol lactate from Fresenius Kabi USA, LLC, validating the generic product HALOPERIDOL LAC…
-
FDA approval · 2008-10-30FDA Approved: RISPERIDONE — Original Application (Torrent Pharmaceuticals Limited)
FDA approves Torrent Pharmaceuticals Limited's original application for risperidone, providing a generic version of the antipsychotic.
-
FDA approval · 2008-10-16FDA Approved: RISPERIDONE — Original Application (Zydus Lifesciences Limited)
FDA approved an original abbreviated new drug application for risperidone by Zydus Lifesciences Limited, enabling the sale of a generic risp…
-
FDA approval · 2008-10-08FDA Approved: RISPERDAL CONSTA — Supplemental Application (Janssen Pharmaceuticals, Inc.)
FDA approved a supplemental application for RISPERDAL CONSTA (risperidone) from Janssen Pharmaceuticals, indicating an approved addition or …
-
FDA approval · 2008-09-08FDA Approved: LOXAPINE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved Actavis Pharma's supplemental application for LOXAPINE (LOXAPINE) under ANDA 072206. The action constitutes a supplemental appr…
-
FDA approval · 2008-09-08FDA Approved: LOXAPINE — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved a supplemental application from Actavis Pharma, Inc. for LOXAPINE (loxapine), establishing a generic loxapine product.
-
FDA approval · 2008-08-26FDA Approved: INVEGA — Supplemental Application (Janssen Pharmaceuticals, Inc.)
The FDA approved a supplemental application for INVEGA (paliperidone) submitted by Janssen Pharmaceuticals, Inc.
-
FDA approval · 2008-08-19FDA Approved: FLUPHENAZINE DECANOATE — Supplemental Application (Mylan Institutional LLC)
FDA approved a supplemental application for Fluphenazine Decanoate submitted by Mylan Institutional LLC. Fluphenazine Decanoate is a long-ac…
-
FDA approval · 2008-08-19FDA Approved: TRIFLUOPERAZINE HYDROCHLORIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for trifluoperazine hydrochloride from Mylan Pharmaceuticals Inc., authorizing changes described…
-
FDA approval · 2008-08-19FDA Approved: FLUPHENAZINE DECANOATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for Fluphenazine decanoate from Hikma Pharmaceuticals USA, indicating updated regulatory authori…
-
FDA approval · 2008-08-19FDA Approved: HALOPERIDOL DECANOATE — Supplemental Application (Mylan Institutional LLC)
FDA approved a supplemental application for HALOPERIDOL DECANOATE by Mylan Institutional LLC, approving the generic long-acting injectable f…
-
FDA approval · 2008-08-14FDA Approved: ZYPREXA INTRAMUSCULAR — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Zyprexa Intramuscular (olanzapine), adding an intramuscular formulation to the product. This…
-
FDA approval · 2008-08-14FDA Approved: RISPERIDONE — Supplemental Application (Janssen Pharmaceutical, Inc.)
FDA approved a supplemental application for risperidone from Janssen Pharmaceuticals, updating the drug's labeling.
-
FDA approval · 2008-08-14FDA Approved: GEODON — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for Geodon (ziprasidone) submitted by Viatris Specialty LLC.
-
FDA approval · 2008-08-14FDA Approved: HALOPERIDOL DECANOATE — Supplemental Application (Patriot Pharmaceuticals LLC)
FDA approved a supplemental application for Haloperidol Decanoate submitted by Patriot Pharmaceuticals LLC. The action concerns the approval…
-
FDA approval · 2008-08-14FDA Approved: INVEGA — Supplemental Application (Janssen Pharmaceuticals, Inc.)
FDA approved a supplemental NDA for INVEGA (paliperidone) submitted by Janssen Pharmaceuticals, Inc., updating the label to reflect the appr…
-
FDA approval · 2008-08-14FDA Approved: GEODON — Supplemental Application (Viatris Specialty LLC)
FDA approves a supplemental application for Geodon (ziprasidone mesylate) filed by Viatris Specialty LLC.
-
FDA approval · 2008-07-25FDA Approved: FLUPHENAZINE HYDROCHLORIDE — Supplemental Application (Lannett Company, Inc.)
FDA approved a supplemental application for fluphenazine hydrochloride by Lannett Company, Inc., confirming regulatory approval for this gen…